1. Home
  2. YOTA vs LSB Comparison

YOTA vs LSB Comparison

Compare YOTA & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YOTA
  • LSB
  • Stock Information
  • Founded
  • YOTA 2021
  • LSB 2002
  • Country
  • YOTA United States
  • LSB China
  • Employees
  • YOTA N/A
  • LSB N/A
  • Industry
  • YOTA Farming/Seeds/Milling
  • LSB
  • Sector
  • YOTA Consumer Staples
  • LSB
  • Exchange
  • YOTA Nasdaq
  • LSB NYSE
  • Market Cap
  • YOTA 43.9M
  • LSB 41.2M
  • IPO Year
  • YOTA 2022
  • LSB N/A
  • Fundamental
  • Price
  • YOTA $11.25
  • LSB $2.60
  • Analyst Decision
  • YOTA
  • LSB
  • Analyst Count
  • YOTA 0
  • LSB 0
  • Target Price
  • YOTA N/A
  • LSB N/A
  • AVG Volume (30 Days)
  • YOTA 1.3K
  • LSB 73.7K
  • Earning Date
  • YOTA 01-01-0001
  • LSB 11-29-2024
  • Dividend Yield
  • YOTA N/A
  • LSB N/A
  • EPS Growth
  • YOTA 35.55
  • LSB N/A
  • EPS
  • YOTA 0.13
  • LSB N/A
  • Revenue
  • YOTA N/A
  • LSB $79,415,311.00
  • Revenue This Year
  • YOTA N/A
  • LSB $39.33
  • Revenue Next Year
  • YOTA N/A
  • LSB $75.61
  • P/E Ratio
  • YOTA $85.06
  • LSB N/A
  • Revenue Growth
  • YOTA N/A
  • LSB N/A
  • 52 Week Low
  • YOTA $10.35
  • LSB $1.88
  • 52 Week High
  • YOTA $15.49
  • LSB $11.20
  • Technical
  • Relative Strength Index (RSI)
  • YOTA 72.10
  • LSB 43.52
  • Support Level
  • YOTA $11.17
  • LSB $2.36
  • Resistance Level
  • YOTA $11.23
  • LSB $2.79
  • Average True Range (ATR)
  • YOTA 0.03
  • LSB 0.48
  • MACD
  • YOTA 0.01
  • LSB 0.12
  • Stochastic Oscillator
  • YOTA 100.00
  • LSB 46.15

About YOTA Yotta Acquisition Corporation

Yotta Acquisition Corp is a shell company.

About LSB LAKESHORE BIOPHARMA CO LTD

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: